Abstract
Background and Aims : Lipid lowering treatment (LLT) and LDL-C target across CV risk categories might prompt consideration on further lower LDL-C levels advocated by EAS/ESC guidelines.The aim was to provide prevalence, clinical characteristics,LLT across different CV risk classes at the time of publication of current ESC/EAS Guidelines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
